Online citations, reference lists, and bibliographies.
← Back to Search

Production Of Lipid Microparticles Containing Bioactive Molecules Functionalized With PEG

K. Vezzù, D. Borin, A. Bertucco, Sara Bersani, S. Salmaso, P. Caliceti
Published 2010 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
The functionalization of bioactive principles is a relevant issue as it allows increasing their stability, to raise the hydrophilic properties of hydrophobic materials, to reduce the absorption from macrophages and the proteolytic degradation. For this reason, we have functionalized a model protein (Ribonuclease A) with polyethylene glycol (PEG5000). We have investigated the production of lipid/PEG particles incorporating this active principle by a supercritical fluid technology (particles from gas saturated solution, PGSS) to obtain solid micro- and nanoparticles. Runs were carried out to study the process conditions; thus, the effects of the operative variables, such as temperature, pressure and organic solvent, were optimized to obtain micrometric particles. The particles produced were characterized by static light scattering (SLS) to determine their mean and distribution size. The better operative conditions were employed to produce microparticles incorporating Ribonuclease A (RNAse) as both native and PEGylated form. The BCA test was applied to determine the maximum amount of protein incorporated in the particles and the in vitro release. The retained enzymatic activity of proteins after the PEGylation and after the micronization process was also determined by spectrophotometric evaluation.
This paper references
10.1016/S0169-409X(02)00180-1
Effective drug delivery by PEGylated drug conjugates.
R. Greenwald (2003)
10.1016/S0921-8610(96)80039-2
Powder generation from polyethyleneglycols with compressible fluids
E. Weidner (1996)
10.1016/0003-2697(66)90275-2
Determination of free amino groups in proteins by trinitrobenzenesulfonic acid.
A. Habeeb (1966)
10.1016/S0378-5173(96)04838-7
Improvement of nifedipine dissolution characteristics using supercritical CO2
P. Senčar-Božič (1997)
10.1016/j.biomaterials.2009.01.026
Reduction-sensitive polymers and bioconjugates for biomedical applications.
F. Meng (2009)
10.1517/17425247.2.1.29
Commercial challenges of protein drug delivery
L. Brown (2005)
10.1002/AIC.11543
Solid–liquid equilibria of multicomponent lipid mixtures under CO2 pressure: Measurement and thermodynamic modeling
K. Vezzù (2008)
10.1021/MA00049A007
Glass transition behavior including retrograde vitrification of polymers with compressed fluid diluents
P. Condo (1992)
10.1016/J.JCONREL.2004.07.017
The production of protein-loaded microparticles by supercritical fluid enhanced mixing and spraying.
M. Whitaker (2005)
10.1016/J.COSSMS.2003.11.002
Particles formation and particle design using supercritical fluids
Ž. Knez (2003)
10.1016/J.IJPHARM.2004.09.003
Nisin-loaded poly-L-lactide nano-particles produced by CO2 anti-solvent precipitation for sustained antimicrobial activity.
S. Salmaso (2004)
10.1016/0076-6879(90)82008-P
Quantitation of protein.
C. Stoscheck (1990)
10.1016/S0896-8446(01)00064-X
Particle design using supercritical fluids: Literature and patent survey
Jennifer Jung (2001)
Camptothecin delivery systems: the utility of amino acid spacers for the conjugation of camptothecin with polyethylene glycol to create prodrugs.
C. Conover (1999)
10.1016/J.BIOMATERIALS.2006.09.047
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
J. Cheng (2007)
10.1002/jps.21434
Production of solid lipid submicron particles for protein delivery using a novel supercritical gas-assisted melting atomization process.
S. Salmaso (2009)
10.1016/S0167-7799(01)01846-7
Protein therapeutics: promises and challenges for the 21st century.
Z. Weng (2002)
10.1016/j.ijpharm.2009.06.014
Biopharmaceutical characterisation of insulin and recombinant human growth hormone loaded lipid submicron particles produced by supercritical gas micro-atomisation.
S. Salmaso (2009)
10.1016/J.JCONREL.2005.09.050
Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
Deshan Yu (2005)
10.1021/IE030278A
Thermodynamic Analysis of Micronization Processes from Gas-Saturated Solution
N. Elvassore (2003)
10.1042/BJ0740234
Spectrophotometric assay of bovine pancreatic ribonuclease by the use of cytidine 2':3'-phosphate.
E. M. Crook (1960)
10.1016/J.ADDR.2007.04.007
Solid lipid nanoparticles as a drug delivery system for peptides and proteins.
A. Almeida (2007)
10.1016/S0168-3659(01)00331-5
PEG drugs: an overview.
R. Greenwald (2001)
10.1016/J.JCONREL.2003.10.015
Effective protein release from PEG/PLA nano-particles produced by compressed gas anti-solvent precipitation techniques.
P. Caliceti (2004)
10.1021/IE0004904
Production of Protein-Loaded Polymeric Microcapsules by Compressed CO2 in a Mixed Solvent
N. Elvassore (2001)
10.1039/B411187G
Supercritical fluid assisted melting of poly(ethylene glycol): a new solvent-free route to microparticles
J. Hao (2005)
10.1021/IE030199Z
A Review of CO2 Applications in the Processing of Polymers
D. Tomasko (2003)
10.1016/j.ddtec.2006.03.001
Enhancing exposure of protein therapeutics.
J. Beals (2006)
10.1016/J.SUPFLU.2004.10.006
Formation of polymer particles with supercritical fluids: A review
Sang-Do Yeo (2005)
10.1002/JMR.300030206
Effects of monomethoxypoly(ethylene glycol) modification of ribonuclease on antibody recognition, substrate accessibility and conformational stability
P. Caliceti (1990)
10.1002/JPS.1113
Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques.
N. Elvassore (2001)
10.1016/J.ADDR.2003.12.002
Solid lipid nanoparticles for parenteral drug delivery.
S. Wissing (2004)
10.1155/2009/781247
Production of Lipid Microparticles Magnetically Active by a Supercritical Fluid-Based Process
K. Vezzù (2009)



This paper is referenced by
10.4155/tde.13.146
Critical gases for critical issues: CO2 technologies for oral drug delivery.
H. Danan (2014)
10.1016/J.SUPFLU.2017.12.038
Current situation and perspectives in drug formulation by using supercritical fluid technology
E. Badens (2017)
10.1093/FQSAFE/FYY008
Application of supercritical and subcritical fluids in food processing
M. K. Hrnčič (2018)
10.1201/B19242-8
Development of Hybrid Structured Particles Prepared through the PGSS® Process
V. C. Gonçalves (2015)
10.1016/J.JFOODENG.2016.01.014
Formation of solid lipid microparticles from fully hydrogenated canola oil using supercritical carbon dioxide
O. Çiftçi (2016)
10.1002/adhm.201700433
Supercritical Fluid Technology: An Emphasis on Drug Delivery and Related Biomedical Applications
Ranjith Kumar Kankala (2017)
10.1021/jp207917n
Effect of high pressure CO2 on the structure of PMMA: a FT-IR study.
V. Di Noto (2011)
10.1016/J.SUPFLU.2015.07.010
Curcumin-loaded solid lipid particles by PGSS technology
A. S. Pedro (2016)
Application of Supercritical Fluid Technology for Preparation of Drug Loaded Solid Lipid Nanoparticles
Z. Akbari (2020)
10.1016/J.POWTEC.2011.11.048
Composite polymer-Fe3O4 microparticles for biomedical applications, produced by Supercritical Assisted Atomization
R. Adami (2012)
10.1186/1556-276X-8-386
Characteristics of lipid micro- and nanoparticles based on supercritical formation for potential pharmaceutical application
I. E. Santo (2013)
10.1016/J.JCT.2013.10.007
Measurement and modelling of binary (solid+liquid+vapour) equilibria involving lipids and CO2
Tamara P.P. Freire (2014)
10.12691/AJMSM-2-5-5
Development and Characterization of Buccal Bilayer Tablets containing Microparticles with Ibuprofen
J. Conceição (2014)
Formation of Bioactive-Carrier Hollow Solid Lipid Micro- and Nanoparticles
Junsi Yang (2016)
10.5772/58405
Techniques for the Preparation of Solid Lipid Nano and Microparticles
L. Battaglia (2014)
10.1016/J.SUPFLU.2016.05.036
Encapsulation of Vitamin B2 in solid lipid nanoparticles using supercritical CO2
R. Couto (2017)
10.1016/J.POWTEC.2011.10.011
Formulation of β-carotene with poly-(ε-caprolactones) by PGSS process
E. Paz (2012)
Current situation and perspectives in drug formulation by using supercritical fl uid technology
E. Badens (2019)
10.1201/B19242-8
Methods for Particle Production: Antisolvent Techniques
C. D. Pascual (2015)
10.1016/j.ijpharm.2014.11.003
Development of multicore hybrid particles for drug delivery through the precipitation of CO2 saturated emulsions.
V. S. Gonçalves (2015)
10.1016/j.foodchem.2017.03.109
Encapsulation of fish oil into hollow solid lipid micro- and nanoparticles using carbon dioxide.
Junsi Yang (2017)
10.1016/J.SCP.2017.07.002
Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery
P. Ganesan (2017)
10.3390/ma4112017
Dense CO2 as a Solute, Co-Solute or Co-Solvent in Particle Formation Processes: A Review
Ana V. M. Nunes (2011)
Development of curcumin lipid formulations for food applications: transport, permeability and safety evaluation on a mucus-secreting intestinal epithelial cell model
João Paulo Caseiro Baixinho (2018)
10.1039/C5RA22452G
Formulation of pea protein for increased satiety and improved foaming properties
C. S. Carmo (2016)
10.1016/J.FBP.2016.01.004
Formation of hollow solid lipid micro- and nanoparticles using supercritical carbon dioxide
Junsi Yang (2016)
10.1016/B978-0-444-62696-7.00002-2
Particle Formation Using Sub- and Supercritical Fluids
Ž. Knez (2014)
10.1201/B19038-27
Supercritical Fluid Technology for Encapsulation
Ángel Martín (2015)
10.1007/978-3-319-24040-4_20
Food Processing Using Supercritical Fluids
Ž. Knez (2016)
Semantic Scholar Logo Some data provided by SemanticScholar